Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 3, 2024--
Source: eagletribune.com
Jay Backstrom News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jay Backstrom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jay Backstrom Today - Breaking & Trending Today
Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
- Updated safety and efficacy results on SRK-181 will be featured in an oral presentation on Monday, June 3rd, at 1:50 p.m CDT/2:50 p.m. EDT - Company will host conference call to discuss the data on...
Source: marketscreener.com
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
22.05.2024 - Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental ... Seite 1
Source: wallstreet-online.de
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced the appointm...
Source: pharmiweb.com
Scholar Rock Says FDA Clears Application for Trial of Obesity Treatment Apitegromab
By Denny Jacob Scholar Rock Holding said the Food and Drug Administration cleared its investigational new drug application for its Phase 2 trial of...
Source: marketwatch.com